Vannuffel P, Laterre P F, Bouyer M, Gigi J, Vandercam B, Reynaert M, Gala J L
Laboratory of Applied Molecular Technology, St. Luc University Hospital, Brussels, Belgium.
J Clin Microbiol. 1998 Aug;36(8):2366-8. doi: 10.1128/JCM.36.8.2366-2368.1998.
Multiplex amplification of femA and mecA genetic determinants allowed an early and rapid identification of methicillin-resistant Staphylococcus aureus (MRSA) in endotracheal aspirates of mechanically ventilated patients. femA and/or mecA amplification and bacteriological results were concordant in 57 of 60 samples. In all three discrepant cases, complementary bacteriological tests confirmed the presence of MRSA first identified by molecular analysis. These results underline the value and rapidity of this molecular diagnosis for MRSA infection and control surveillance in intensive care units. Rapid MRSA detection is expected to have a significant clinical impact not only on patient outcome but also on the costs for isolation and treatment.
对femA和mecA基因决定簇进行多重扩增,可在机械通气患者的气管内吸出物中早期快速鉴定耐甲氧西林金黄色葡萄球菌(MRSA)。60份样本中的57份,femA和/或mecA扩增结果与细菌学结果一致。在所有3例结果不符的病例中,补充细菌学检测证实了分子分析首次鉴定出的MRSA的存在。这些结果强调了这种分子诊断方法在重症监护病房MRSA感染检测及控制监测中的价值和快速性。快速检测MRSA不仅有望对患者的治疗结果产生重大临床影响,还会对隔离和治疗成本产生影响。